Equities

Memphasys Ltd

Memphasys Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.006
  • Today's Change0.001 / 9.09%
  • Shares traded200.00k
  • 1 Year change-42.47%
  • Beta1.3893
Data delayed at least 20 minutes, as of Nov 21 2024 23:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.

  • Revenue in AUD (TTM)60.00k
  • Net income in AUD-4.44m
  • Incorporated2006
  • Employees24.00
  • Location
    Memphasys Ltd30 Richmond RdHOMEBUSH WEST 2140AustraliaAUS
  • Phone+61 28415-7300
  • Fax+61 28415-7399
  • Websitehttps://www.memphasys.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VIP Gloves Ltd1.78m-13.45m2.39m4.00------1.34-0.017-0.0170.0023-0.00030.12498.281.48---94.23-20.80-164.08-35.48-98.2516.96-754.43-24.121.16-9.771.10---83.52-31.08-82.31---65.46--
Bluechiip Ltd484.69k-5.81m3.62m7.00--5.00--7.46-0.0174-0.01740.00090.00060.08850.05590.4982---106.19-56.18-350.57-75.2662.4263.81-1,199.30-827.990.2818-29.060.5065---47.03-13.91-15.31--19.38--
Osteopore Ltd2.70m-3.51m4.39m----2.41--1.63-0.0527-0.05270.0330.01570.56781.464.43---73.93---172.14--83.51---130.20--1.25-14.960.3768--31.02---16.13------
Opyl Ltd397.64k-3.13m4.61m3.00------11.59-0.0211-0.02110.0027-0.00050.7093--3.51---558.41-163.91---346.90-----787.24-272.11---7.57-----35.65-15.67-81.33------
Tali Digital Ltd146.23k-3.12m4.94m5.00--2.30--33.80-0.001-0.0010.000040.00070.0284--3.89---60.62-56.17-67.17-63.99-----2,131.60-690.28----0.00---81.28-30.68-38.01------
Global Health Limited8.67m-1.31m7.55m49.00------0.8707-0.0226-0.02260.1493-0.052.80--11.81---42.35-34.67---112.4181.1878.53-15.14-32.95---12.78----10.869.4283.71---55.12--
Adherium Ltd2.29m-10.22m7.59m----1.13--3.31-0.0275-0.02750.00620.00890.20311.051.22---90.61-110.82-129.82-157.5635.3349.25-446.19-413.922.43--0.0142---54.47-4.27-3.71---83.48--
Visioneering Technologies Inc13.23m-5.32m7.71m----1.16--0.5825-0.1205-0.12050.29140.12091.212.087.06---48.75-76.38-75.48-97.7056.7444.90-40.22-98.702.44--0.00--19.0121.3641.05------
Uscom Ltd3.77m-2.07m7.76m11.00--2.48--2.06-0.0118-0.01180.02140.01250.73160.887411.28---40.23-30.60-53.05-36.9783.8086.20-54.99-53.502.54-17.760.2443--38.730.997719.92---12.44--
Inhalerx Ltd891.64k-756.82k8.24m--------9.24-0.004-0.0040.0047-0.00031.05--2.81---88.94-80.34-252.07-99.88-----84.88-500.13---11.571.19--2,226.0922.7925.10------
Memphasys Ltd60.00k-4.44m9.70m24.00--1.11--161.62-0.004-0.0040.000050.0050.00440.3952-----32.78-19.51-54.58-25.222.67---7,403.38-12,238.500.2767-13.900.4104--290.37---30.55---21.39--
Atomo Diagnostics Ltd4.24m-6.85m12.78m----1.27--3.02-0.0108-0.01080.00670.01580.30441.253.09---49.17-31.42-54.41-34.2041.4842.58-161.56-120.994.84--0.0083--66.6351.0131.23---54.38--
Data as of Nov 21 2024. Currency figures normalised to Memphasys Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.